RSS SubscribeBoosted ‘Natural Killer’ Cells Could Lead to Off-The-Shelf Cancer Immunotherapy
By David Nield – Science alert
Modifications to a type of immune cell programmed to recognize and kill cancerous tumors could make them even more effective assassins.
Researchers from the Massachusetts Institute of Technology (MIT) and Harvard Medical School have found a novel way to engineer chimeric antigen receptor natural killer (CAR-NK) cells to ensure they’re not rejected by the body’s immune system as foes rather than friends.
Legal Notice / Disclaimer
Ahead of the Herd newsletter, aheadoftheherd.com, hereafter known as AOTH.Please read the entire Disclaimer carefully before you use this website or read the newsletter. If you do not agree to all the AOTH/Richard Mills Disclaimer, do not access/read this website/newsletter/article, or any of its pages. By reading/using this AOTH/Richard Mills website/newsletter/article, and whether you actually read this Disclaimer, you are deemed to have accepted it.
Related posts
October 27, 2025
September 15, 2025
July 4, 2025
September 14, 2024
